Key Takeaways:
Investors who bought Alibaba Group securities between June 26, 2025 and June 24, 2026 face an Oct. 5 lead plaintiff deadline.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," Peretz Bronstein, founding partner at Bronstein, Gewirtz & Grossman, said.
The complaint alleges Alibaba failed to disclose that it was directly or indirectly controlled by or affiliated with China's Ministry of Industry and Information Technology, making it a Chinese military company under the National Defense Authorization Act. It also alleges the risk of Alibaba carrying out distillation attacks against third-party AI models was ongoing, not the hypothetical or inadvertent occurrence described in annual reports.
The U.S. Department of Defense on June 8, 2026 added Alibaba to its updated list of Chinese military companies. Shares fell $4.69, or about 3.9 percent, over two trading days to close at $115.38 on June 10. On June 24, Bloomberg reported that Anthropic PBC accused Alibaba's Qwen AI lab of waging a large-scale effort to "illicitly" access its Claude model using thousands of fraudulent accounts. Alibaba's American depositary shares dropped $2.80, or 2.7 percent, to $99.80 that day.
Rosen Law Firm, which said it first filed the action, is among at least four firms — including Bronstein Gewirtz & Grossman, Glancy Prongay Wolke & Rotter and Levi & Korsinsky — reminding investors of the deadline. Rosen said it has achieved the largest securities class action settlement against a Chinese company.
Investors who suffered losses may move the court no later than Oct. 5, 2026, to request appointment as lead plaintiff, the representative party directing the litigation. Serving as lead plaintiff is not required to share in any potential recovery, and firms are representing investors on a contingency fee basis.
The deadline tests whether investors consolidate claims against one of China's largest technology companies as it faces dual scrutiny over military-company designation and AI model access. Alibaba's next catalyst is the lead plaintiff appointment hearing, which typically follows the Oct. 5 deadline.
This article is for informational purposes only and does not constitute investment advice.
